Who We Are

Home / Who We Are

Who We Are

Dr Ian Evetts

Ian has more than 25 years of experience in the pharmaceutical industry, gained through senior positions in sales, marketing, business development & licensing in both multinational companies and biotech. Through Atebion BDS, he assists spin-outs, BioTech and Major Pharmaceutical Companies in their strategic investment decisions.
Read More →

Luke Evetts

Luke Evetts

Throat Specialist

Luke assists and supports Atebion BDS in matters requiring commercial legal expertise. He is Managing Director of Evetts Legal, a boutique law firm specialising in providing legal support in the pharmaceutical sector.
Read More →

Dr David Simpson

Dr David Simpson

Cardiologist

Dave Simpson PhD has spent over 15 years’ in the biotherapeutics industry developing and commercialising biologics with Cobra Biologics, Eden Biodesign and Actavis (now Allergan) and is currently the CEO of Glythera Ltd, an Antibody Drug Conjugate development company.
Read More →

Tim Dempsey

Tim Dempsey

Rehabilitation Therapy

Tim Dempsey assists Atebion BDS in investor-related projects, whether this relates to defining investor strategy, brokering investor / VC meetings for Investment Rounds, providing company valuations or for the general support of investment decisions.
Read More →

Testimonials

What Our Clients Say